Skip to main content
SpringerLink
Log in

Methadone maintenance treatment: An update

  • Original Paper
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

Available data (this review includes old major articles and recent articles) show that, although results are heterogenous, methadone maintenance treatments (MMTs) have a real efficiency not only to reduce illicit opiate abuse (50–80% of patients under MMT did not use heroin in the preceding month) but also to reduce criminality, HIV risks and mortality, and to improve social rehabilitation, without inducing other alternative substance abuse. A minority of patients (perhaps 5–20%) stay on MMT on a very long-term basis (more than 10 years). Efficiency of MMTs are rather poorly related to patients' variables, with the exception of a moderately deleterious effect of a low age at onset of opiate dependance, a precocious or high involvement in criminality and an abuse of non-opiate drugs. On the other hand, variables related to treatment play a more important role in explaining heterogeneity of results. Optimal daily dose, high quality of medical and psycho-social services, clear orientation towards social rehabilitation and treatment retention (to allow a sufficient duration of treatment) and slow detoxification regimen of well-stabilized patients are all factors contributing to better results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bale RN, Van Stone WW, Engelsing, Kuldau JM, Engelsing TMJ, Elashoff RM, Zarcone VP (1980) Therapeutic communities vs methadone maintenance. Arch Gen Psychiatry 37:179–193

    Google Scholar 

  2. Ball JC, Ross A (1991) The effectiveness of methadone maintenance treatment. Springer, Berlin Heidelberg New York

    Google Scholar 

  3. Barthwell A, Senay E, Marks R, White R (1989) Patients successfully maintained with methadone escaped human immunodeficiency virus infection. Arch Gen Psychiatry 46:9570958

    Google Scholar 

  4. Bell J, Bowron P, Lewis J, Batey R (1990) Serum levels of methadone in maintenance clients who persist in illicit drug use. Br J Addict 85:1599–1602

    Google Scholar 

  5. Bell J, Digiusto E, Byth K (1992) Who should receive methadone maintenance? Br J Addict 87:689–694

    Google Scholar 

  6. Bell J, Seres V, Bowron, P, Lewis J, Batey R (1988) The use of serum methadone levels in patients receiving methadone maintenance. Clin Pharmacol Ther 43:623–629

    Google Scholar 

  7. Bertschy G, Calanca A (1993) Choix de la dose de méthadone: la souplesse reste d'actualité. Med Hyg 51:2238–2241

    Google Scholar 

  8. Bickel WK, Amass L (1992) The relationship of mean daily blood alcohol levels to admission MAST, clinic absenteeism and depression in alcoholic methadone patients. Drug Alcohol Depend 32:113–118

    Google Scholar 

  9. Brecht ML, Anglin MD (1990) Conditional factors of maturing out: legal supervision and treatment. Int J Addict 25:393–407

    Google Scholar 

  10. Briefer JF, Deglon JJ (1992) Traitement de méthadone et comportements à risque de transmision du VIH. Med Hyg 50:1544–1549

    Google Scholar 

  11. Brown BS, Watters JK, Iglehart AS, Akisn C (1982–1983) Methadone maintenance dosage levels and program retention. Am J Durg Alcohol Abuse 9:129–139

    Google Scholar 

  12. Caplehorn JRM, Bell J (1991) Methadone dosage and retention of patients in maintenance treatment. Med J Aust 154:195–199.

    Google Scholar 

  13. Caplehorn JRM, Bell J, David G, Kleinbaum, Gebski VJ (1993) Methadone dose and heroin use during maintenance treatment. Addiction 88:119–124

    Google Scholar 

  14. Caplehorn JRM, Dalton SYN, Cluff MC, Petrenas AM (1994) Retention in methadone maintenance and heroin addicts, risk of death. Addiction 89:203–207

    Google Scholar 

  15. Caplehorn JRM, McNeil DR, Kleinbaum DG (1993a) Clinic policy and retention in methadone maintenance. Int J Addict 28:73–89

    Google Scholar 

  16. Caplehorn JRM, Reilly DK, Wodak A (1993) Detected heroin use in an Australian methadone maintenance program. J Subst Abuse Treat 10:553–559

    Google Scholar 

  17. Condelli WS (1993) Strategies for increasing retention in methadone programs. J Psychoactive Drugs 25:143–147

    Google Scholar 

  18. Condelli WS (Dunteman GH (1993) Exposure to methadone programs and heroin use. Am J Drug Alcohol Abuse 19:65–78

    Google Scholar 

  19. Cooper J (1989) Methadone treatment and acquired immunodeficiency syndrome. JAMA 262:1664–1668

    Google Scholar 

  20. Cushman P (1978a) Recent developments in chemotherapy of narcotic addiction. Ann N Y Acad Sci 311:165–172

    Google Scholar 

  21. Cushman P (1978b) Abstinence following detoxification and methadone maintenance treatment. Am J Med 65:46–52

    Google Scholar 

  22. Cushman P (1988) Cocaine use in a population of drug abusers on methadone. Hosp Community Psychiatry 39:1205–1206

    Google Scholar 

  23. Cushman P, Dole VP (1973) Detoxification of rehabilitated methadone-maintained pafients. JAMA 226:747–752

    Google Scholar 

  24. D'Aunno T, Vaughn TE (1992) Variations in methadone treatment practice. JAMA 267:253–258

    Google Scholar 

  25. Desland M, Batey R (1991) High retention rate within a prospective study of heroin users. Br J Addict 86:859–865

    Google Scholar 

  26. Dole VP, Joseph H (1978) Recent developments in chemotherapy of narcotic addiction. Ann N Y Acad Sci 311:181–189

    Google Scholar 

  27. Dole VP, Nyswander M (1965) A medical treatment for diacetylmorphine (heroin) addiction. JAMA 193:80–84

    Google Scholar 

  28. El Bassel N, Schilling RF, Turnbull JE, Su KH (1993). Correlates of alcohol use among methadone patients. Clin Exp Res 17:681–686

    Google Scholar 

  29. Fairbank JA, Dunteman GH, Condelli WS (1993) Do methadone patients substitute other drugs for heroin? Predicting substance use at 1-year follow-up. Am J Drug Alcohol Abuse 19:465–474

    Google Scholar 

  30. Fisher D, Anglin MD (1987) Survival Analysis in Drug Program Evaluation. Part I. Overall program effectiveness. Int J Addict 22:115–134

    Google Scholar 

  31. Foy A, Drinkwater V, White A (1989) A prospective clinical audit of methadone maintenance therapy at the Royal New-castle Hospital. Med J Aust 151:332–337

    Google Scholar 

  32. French MT, Zarkin GA, Hubbard RL, Rachal JV (1993) The effects of time in drug abuse treatment and employment on posttreatment drug use and criminal activity. Am J Drug Alcohol Abuse 19:19–33

    Google Scholar 

  33. Frischer M, Bloor M, Goldberg D, Clark J, Green S, McKeganey N (1993) Mortality among injecting drug users: a critical reappraisal. J Epidemiol Community Health 47:59–63

    Google Scholar 

  34. Goehl L, Nunes E, Quitkin F, Hilton I (1993) Social networks and methadone treatment outcome: The costs and benefits of social ties. Am J Drug Alcohol Abuse 19:251–262

    Google Scholar 

  35. Gossop M, Grant M (1991) A six-country survey of the content and structure of heroin treatment programmes using methadone. Br J Addict 86:1151–1160

    Google Scholar 

  36. Grabowski J, Rhoades H, Elk R, Schmitz J, Creson D (1993) Methadone dosage, cocaine and opiate abuse. Am J Psychiatry 150:675

    Google Scholar 

  37. Grönbladh L, Ohlund LS, Gunne LM (1990) Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatr Scand 82:223–227

    Google Scholar 

  38. Gunne LM, Grönbladh L (1981) The swedish methadone maintenance program: a controlled study. Drug Alcohol Depend 7:249–256

    Google Scholar 

  39. Haastrup S, Jepsen PW (1984) Seven year follow-up of 300 young drug abusers. Acta Psychaitr Scand 70:503–509

    Google Scholar 

  40. Havassy B, Hargreaves WA, De Barros L (1979) Self-regulation of dose in methadone maintenance with contingent privileges. Addict Behav 4:31–38

    Google Scholar 

  41. Hser YI, Anglin MD, Liu Y (1990–91) A survival analysis of gender and ethnic differences in responsiveness to methadone maintenance treatment. Int J Addict 25:1295–1315

    Google Scholar 

  42. Hser YI, Anglin MD, Powers K (1993) A 24-year follow-up of California narcotics addicts. Arch Gen Psychiatry 50:577–584

    Google Scholar 

  43. Iguchi MY, Handelsman L, Bickel WK, Griffiths RR (1993) Benzodiazepine and sedative use/abuse by methadone maintenance clients. Drug Alcohol Depend 323:257–266

    Google Scholar 

  44. Joseph H, Appel P (1991) Historical perspectives and public health issues. In: Parrino MW, Consensus Panel Chair (eds) State methadone treatment guidelines. U.S. Department of Health and Human Services, Rockville, pp 39–64

    Google Scholar 

  45. Judson BA, Goldstein A (1982) Prediction of long-term out-come for heroin addicts admitted to a methadone maintenance program. Drug Alcohol Depend 10:383–391

    Google Scholar 

  46. Kang SY, De Leon G (1993) Correlates of drug injection behaviors among methadone outpatients. Am J Drug Alcohol Abuse 19:107–118

    Google Scholar 

  47. Kanof PD, Aronson MJ, Ness R (1993) Organic mood syndrome associated with detoxification from methadone maintenance. Am J Psychiatry 150:423–428

    Google Scholar 

  48. Kidorf M, Stitzer ML (1993) Descriptive analysis of cocaine use of methadone patients. Drug Alcohol Depend 32:267–275

    Google Scholar 

  49. Kosten TR, Rounsavlle BJ, Kleber HD (1986) A 2,5-Year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. Arch Gen Psychiatry 43:733–738

    Google Scholar 

  50. Kreek MJ (1991) A personal retrospective and prospective viewpoint. In: Parrino MW, Consensus Panel Chair (eds) State methadone treatment guidelines. U.S. Department of Health and Human Services, Rockville, pp 255–273

    Google Scholar 

  51. Ladewig D (1988) Erfahrugen mit Methadon in Basel. In: Thommen D (ed). Drogenproblematik im Wandel. ISPA-Press, Lausanne, pp 80–87

    Google Scholar 

  52. Lehmann F, Lauzon P, Amsel R (1993) Methadone maintenance: predictors of outcome in a canadian milieu. J Subst Abuse Treat 10:85–89

    Google Scholar 

  53. Loimer N, Schmid R (1992) The use of plasma levels to optimize methadone maintenance treatment. Drug Alcohol Depend 30:241–246

    Google Scholar 

  54. Longshore D, Hsieh SC, Danila B, Anglin MD (1993) Methadone maintenance and needle/syringe sharing. Int J Addict 28:983–996

    Google Scholar 

  55. McCarthy JJ, Borders OT (1985) Limit setting on drug abuse in methadone maintenance patients. Am J Psychiatry 142:1419–1423

    Google Scholar 

  56. McGlothlin WH, Anglin MD (1981) Shutting off methadone. Arch Gen Psychiatry 38:885–892

    Google Scholar 

  57. McGlothlin WH, Anglin MD (1981) Long-term follow-up of clients of high- and low-dose methadone programs. Arch Gen Psychiatry 38:1055–1063

    Google Scholar 

  58. McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP (1993) The effects of psychosocial services in substance abuse treatment. JAMA 269:1953–1959

    Google Scholar 

  59. McLellan AT, Luborsky L, Woody GE, O'Brien CP, Druley KA (1983) Predicting response to alcohol and drug abuse treatments. Arch Gen Psychiatry 40:620–625

    Google Scholar 

  60. Maddux JF, Desmond DP (1992a) Ten-year follow-up after admission to methadone maintenance. Am J Drug Alcohol Abuse 18:289–303

    Google Scholar 

  61. Maddux JF, Desmond DP (1992b) Methadone maintenance and recovery from opioid dependence. Am J Drug Alcohol Abuse 18:63–74

    Google Scholar 

  62. Martin J, Payte JT, Zweben JE (1991) Methadone maintenance treatment: a primer for physicians. J Psychoactive Drugs 23:165–176

    Google Scholar 

  63. Meystre-Agustoni G, Wietlisbach V, Martin J, Haller-Maslov E (1990) Methadone treatment in medical private practice: outcome according to the number of courses followed. Brit J Addict 85:537–545

    Google Scholar 

  64. Milby JB (1988) Methadone maintenance to abstinence: how many make it? J Nerv Ment Dis 176:409–422

    Google Scholar 

  65. Newman RG, Whitehill WB (1979) Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong. Lancet: 485–488

  66. Novick DM, Joseph H, Croxson TS, Salsitz EA, Wang G, Richman BL, Poretsky L, Keefe JB, Whimbey E (1990) Absence of antibody to human immunodeficiency virus in long-term socially rehabilitated methadone maintenance patients. Arch Intern Med 150:97–99

    Google Scholar 

  67. Novick DM, Ochshorn M, Ghali V, Croxson TS, Mercer WD, Chiorazzi N, Kreek MJ (1989) Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J Pharmacol Exp Ther 250:606–610

    Google Scholar 

  68. Novick DM, Pascarelli EF, Joseph H,Salsitz EA, Richman BL, Des Jarlais C, Anderson M, Dole VP, Nyswander ME (1988) Methadone maintenance patients in general medical practice. JAMA 259:3299–3302

    Google Scholar 

  69. Olié JP, Kecskemeti S, Poirier MF, Laqueille X, Perron JL, Lôo H (1991) Heroïnomanie traitée par méthadone: expérience sur 50 malades. Presse Med 20:1253–1258

    Google Scholar 

  70. Oliveto A, Kosten T, Schottenfeld R, Ziedonis D (1993) Cocaine abuse among methadone-maintained patients. Am J Psychiatry 150: p. 1755

    Google Scholar 

  71. Payte JT, Khuri ET (1991) Principles of methadone dose determination. In: Parrino MW, Consensus Panel Chair (eds) State methadone treatment guidelines. U.S. Department of Health and Human Services. Rockville, pp 101–124

    Google Scholar 

  72. Powers KI, Anglin MD (1993) Cumulative versus stabilizing effects of methadone maintenance: a quasi-experimental study using longitudinal self-report data. Evaluation Rev 17:243–270

    Google Scholar 

  73. Pugliese AC, Maselli A, Hess DJ, Leone A (1976–77) Detoxification of methadone maintenance patients: a follow-up study. Drug Forum 5:359–367

    Google Scholar 

  74. Rawson RA, Ling W (1991) Opioid addiction treatment modalities and some guidelines to their optimal use. J Psychoactive Durgs 23:151–163

    Google Scholar 

  75. Reno RR, Aiken LS (1993) Life activities and life quality of heroin addicts in and out of methadone treatment. Int J Addict 28:211–232

    Google Scholar 

  76. Riordan CE, Mezritz M, Slobetz F, Kleber HD (1976) Successful detoxification from methadone maintenance: follow-up study of 38 patients. JAMA 235:2604–2607

    Google Scholar 

  77. Robins LN (1993) Vietnam veteran's rapid recovery from heroin addiction: a fluke or normal expectation?. Addiction 88:1041–1054

    Google Scholar 

  78. Saxon AJ, Calsyn DA, Kivlahan DA, Roszell DK (1993) Out-come of contingency contracting for illicit drug use in a methadone maintenance program. Drug Alcohol Depend 31:205–214

    Google Scholar 

  79. Schottenfeld RS, O'Malley S, Abdul-Salaam K, O'Connor PG (1993) Decline in intravenous drug use among treatmentseeking opiate users. J Subst Abuse Treat 10:5–10

    Google Scholar 

  80. Segest E, Mygind O, Bay H (1989) The allocation of drug addicls to different types of treatment. An evaluation and a two-year follow-up. Am J Drug Alcohol Abuse 15:41–53

    Google Scholar 

  81. Segest E, Mygind O, Bay H (1990) The influence of prolonged stable methadone maintenance treatment on mortality and employment: an 8-year follow-up. Int J Addict 25:53–63

    Google Scholar 

  82. Senay EC (1985) Methadone maintenance treatment. Int J Addict 20:803–821

    Google Scholar 

  83. Senay EC, Dorus W, Goldberg F, Thornton W (1977) Withdrawal from methadone maintenance: rate of withdrawal and expectation. Arch Gen Psychiatry 34:361–367

    Google Scholar 

  84. Senay EC, Uchtenhagen A (1990) Methadone in the treatment of opioid dependence: a review of the world literature. In: Arif A, Westermeyer J (eds). Methadone maintenance in the management of opioid dependence. Praeger, New York, pp 19–54

    Google Scholar 

  85. Siddiqui NS, Brown LS, Phillips RY, Vargas O, Makuch RW (1992) No seroconversions among steady sex partners of methadone-maintained HIV-1-seropositive injecting drug users in New York City. AIDS 6:1529–1533

    Google Scholar 

  86. Siddiqui NS, Brown LS, Meyer TJ, Gonzalez V (1993) Decline in HIV-1 seroprevalence and low seroconversion rate among injecting drug users at a methadone maintenance program in New York City. J Psychoactive Drugs 25:245–250

    Google Scholar 

  87. Simpson DD, Joe GW, Bracy SA (1982) Six-year follow-up of opioid addicts after admission to treatment. Arch Gen Psychiatry 39:1318–1323

    Google Scholar 

  88. Simpson DD, Joe GW, Lehman WEK, Sells SB (1986) Addiction careers: etiology, treatment, and 12-year follow-up outcomes. J Drug Issues 16:107–121

    Google Scholar 

  89. Simpson DD, Savage LJ, Lloyd MR (1979) Follow-up evaluation of treatment of drug abuse during 1969 to 1972. Arch Gen Psychiatry 36:772–780

    Google Scholar 

  90. Sorensen JL, Trier M, Brummett S, Gold ML, Dumontet R (1992) Withdrawal from methadone maintenance: impact of a tapering network support program. J Subst Abuse Treat 9:21–26

    Google Scholar 

  91. Stark MJ, Campbell BK, Brinkerhoff CV (1990) “Hello, may we help you?” A study of attrition prevention at the time of the first phone contact with substance-abusing clients. Am J Drug Alcohol Abuse 16:67–76

    Google Scholar 

  92. Stimmel B, Goldberg J, Rotkopf E, Cohen M (1977) Ability to remain abstinent after methadone detoxification: a six-year study. JAMA 21:1216–1220

    Google Scholar 

  93. Stitzer M, Bickel WK, Bigelow GE, Liebson IA (1986) Effect of methadone dose contingencies on urinalysis test result of polydrug-abusing methadone-maintenance patients. Drug Alcohol Depend 18:341–348

    Google Scholar 

  94. Strain EC, Stitzer ML, Liebson IA, Bigelow GE (1993a) Dose-response effects of methadone in the treatment of opioid dependence. Ann Intern Med 119:23–27

    Google Scholar 

  95. Strain EC, Stitzer ML, Liebson IA, Bigelow GE (1993b) Methadone dose and treatment outcome. Drug Alcohol Depend 33:105–117

    Google Scholar 

  96. Tennant FS (1987) Inadequate plasma concentrations in some high-dose methadone maintenance patients. Am J Psychiatry 144:1349–1350

    Google Scholar 

  97. Uchtenhagen A (1988) Zur Behandlung Drogenabhängiger mit Methadon: Zürcherische Richtlinien und Auswertung der Therapieresultate. Schweiz Rundsch Med 77:351–356

    Google Scholar 

  98. Uchtenhagen A (1990a) Impact of AIDS epidemiology on methadone policy. In: Arif A, Westermeyer J (eds). Methadone maintenance in the management of opioid dependence. Praeger, New York, pp 8–17

    Google Scholar 

  99. Uchtenhagen A (1990c) Policy and practice of methadone maintenance: an analysis of worldwide experience. In: Arif A, Westermeyer J (eds). Methadone maintenance in the management of opioid dependence. Praeger, New York, pp 54–74

    Google Scholar 

  100. Vaillant GE (1988) What can long-term follow-up teach us about relapse and prevention of relapse in addiction? Br J Addict 83:1147–1157

    Google Scholar 

  101. Watkins KE, Metzger D, Woody G, McLellan AT (1992) High-risk sexual behaviors of intravenous drug users in- and out-of-treatment: implications for the spread of HIV infection. Am J Drug Alcohol Abuse 18:389–398

    Google Scholar 

  102. Weber R, Ledergerber B, Opravil M, Siegenthaler W, Lüthy R (1990) Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone. Br Med J 301:1362–1365

    Google Scholar 

  103. Weddington WW (1990–91) Towards a rehabilitation of methadone maintenance: integration of relapse prevention and aftercare. Int J Addict 25:1201–1224

    Google Scholar 

  104. Weinstein SP, Gottheil E, Sterling RC, DeMaria PA (1993) Long-term methadone maintenance treatment: some clinical examples. J Subst Abuse Treat 10:277–281

    Google Scholar 

  105. Wolff K, Sanderson M, Hay AWM, Raistrick D (1991) Methadone concentrations in plasma and their relationship to drug dosage. Clin Chem 37/2:205–209

    Google Scholar 

  106. Yancovitz SR, Des Jarlais C, Peyser NP, Drew E, Friedmann P, Trigg HL, Robinson JW (1991) A randomized trial of an interim methadone maintenance clinic. Am J Public Health 81:1185–1191

    Google Scholar 

  107. Zanis DA, McLellan AT, Randall M (1994) Can yout trust patient self-reports of drug use during treatment. 35:127–132

  108. Zweben JE (1991) Counseling issues in methadone maintenance treatment. J Psychoactive Drugs 23:177–190

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département Universitaire de Psychiatrie Adulte, Site de Cery, 1008, Prilly-Lausanne, Switzerland

    Gilles Bertschy

Authors
  1. Gilles Bertschy
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bertschy, G. Methadone maintenance treatment: An update. Eur Arch Psychiatry Clin Nuerosci 245, 114–124 (1995). https://doi.org/10.1007/BF02190738

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02190738

Key words

Search

Navigation